Skip to main content

Table 5 Statistical analysis of the SRM

From: A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis

 

Peptide

T

Mean ± SEM

p value

1

ITLLSALVETR

T1

Control: 22,938 ± 11,790; CAS: 418,327 ± 245,046

0.0032

T2

Control: 77,287 ± 41,645; CAS: 1,395,651 ± 811,858

0.0025

T3

Control: 42,469 ± 22,863; CAS: 792,453 ± 460,476

0.0032

2

LYGSEAFATDFQDSAAAK

T1

Control: 32,992 ± 10,156; CAS: 77,827 ± 11,396

0.0055

T2

Control: 42,505 ± 14,734; CAS: 97,228 ± 14,444

0.0095

T3

Control: 31,132 ± 8909; CAS: 75,803 ± 10,252

0.0025

3

AVLDVFEEGTEASAATAVK

T1

Control: 0.024 ± 0.001; CAS: 0.035 ± 0.006

0.0023

T2

Control: 0.022 ± 0.001; CAS: 0.030 ± 0.006

0.0325

T3

Control: 0.024 ± 0.001; CAS: 0.035 ± 0.006

0.0482

  1. The peptide sequence is shown, along with the selected transitions (T) and the statistical significance (p value)